References
- Fuster MM, Esko JD. The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer5(7), 526–542 (2005).
- Chen S, Laroche T, Hamelinck D et al. Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat. Methods4(5), 437–444 (2007).
- Chen S, Haab BB. Antibody microarrays for protein and glycan detection. In: Clinical Proteomics. Van Eyk J, Dunn M (Eds). Wiley, VCH, Weinheim, Germany (2007).
- Haab BB, Dunham MJ, Brown PO. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biology2(2), 4 (2001).
- Hirabayashi J. Lectin-based structural glycomics: glycoproteomics and glycan profiling. Glycoconjugate J.21(1–2), 35–40 (2004).
- Yue T, Goldstein IJ, Hollingsworth MA, Kaul K, Brand RE, Haab BB. The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody–lectin sandwich arrays. Mol. Cell. Proteomics8(7), 1697–1707 (2009).
- Forrester S, Kuick R, Hung KE, Kucherlapati R, Haab BB. Low-volume, high-throughput sandwich immunoassays for profiling plasma proteins in mice: identification of early-stage systemic inflammation in a mouse model of intestinal cancer. Mol. Oncol.1, 216–225 (2007).
- Orchekowski R, Hamelinck D, Li L et al. Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. Cancer Res.65(23), 11193–11202 (2005).
- Yabe R, Itakura Y, Nakamura-Tsuruta S, Iwaki J, Kuno A, Hirabayashi J. Engineering a versatile tandem repeat-type a2–6sialic acid-binding lectin. Biochem. Biophys. Res. Commun.384(2), 204–209 (2009).
- Zeng Z, Hincapie M, Haab BB et al. The development of an integrated platform to identify breast cancer glycoproteome changes in human serum. J. Chromatog. A (2009) (Epub ahead of print).